Structure Therapeutics Hopes To Wow Investors With Cutting-Edge Drug Tech (Pending:GPCR)
Structure Therapeutics is hoping to impress investors with its cutting-edge drugs, strong executive team and bi-continental China-U.S. organization
Source: seekingalpha.com